ENOUGH, an alternative-protein foodtech startup, has revealed that it has secured 40 million Euros in its latest Series C funding round. With an increasing global focus on sustainability and the urgent need to reduce our environmental footprint, more attention is being directed towards alternative forms of proteins. The financing news was reported by global leading legal news provider, JD Supra.
The company’s primary product is ABUNDA mycoprotein, a low-fat, high-protein food source derived from fungi. This innovative and sustainable protein source competes directly with traditional animal-based proteins, offering a more climate-friendly alternative.
ENOUGH aims to leverage the funds from its recent Series C round to expand production and increase the accessibility of its ABUNDA mycoprotein. It’s a significant step forward for the startup, showing increased confidence from financial investors in the alternative protein sector.
ENOUGH isn’t the only startup finding success in this sector. Numerous other companies worldwide are targeting this rapidly growing market, further underlining the potential present in sustainable food production. Multi-million Euro funding rounds such as ENOUGH’s demonstrate the notable investor confidence in this shift towards greener, more sustainable food sources.
This weekly issue is penned by Davis Wright Tremaine LLP. The full details of this development are available on JD Supra.
The backing ENOUGH has received in this funding round illuminates the collective support for changes in our food systems. Investors are demonstrating their belief in the potential of alternatives to move to the forefront of the protein market. As environmental considerations become increasingly pivotal for businesses across all industries, it’s safe to say we can expect to see more investment pouring into alternative protein sources and other green innovations.